NCT07463573 2026-03-11
QLC5508 vs. Chemotherapy in Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma
Qilu Pharmaceutical Co., Ltd.
Phase 3 Not yet recruiting
Qilu Pharmaceutical Co., Ltd.
Mirati Therapeutics Inc.
Luye Pharma Group Ltd.
Onconic Therapeutics Inc.
IMGT Co., Ltd.
TransThera Sciences (Nanjing), Inc.
Shanghai JMT-Bio Inc.
Jiangsu Hansoh Pharmaceutical Co., Ltd.